Latest Articles

Publication Date
All News Scientific
Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer - OncLive

Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer OncLive

Published: July 1, 2024, 7 a.m.
Read Full Article
Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer - OncLive

Dr Porter on Mirvetuximab Soravtansine Plus Pembrolizumab in FRα+ pMMR/MSS Endometrial Cancer OncLive

Published: April 8, 2024, 7 a.m.
Read Full Article
Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer - OncLive

Differentiating Between dMMR and pMMR Subtypes of Endometrial Cancer OncLive

Published: April 2, 2024, 7 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!